Gene expression changes related to immune processes associate with cognitive endophenotypes of schizophrenia

Abstract

Schizophrenia is a heterogeneous disorder characterized by a spectrum of symptoms and many different underlying causes. Thus, instead of using the broad diagnosis, intermediate phenotypes can be used to possibly decrease the underlying complexity of the disorder. Alongside the classical symptoms of delusions and hallucinations, cognitive deficits are a core feature of schizophrenia. To increase our understanding of the biological processes related to these cognitive deficits, we performed a genome-wide gene expression analysis. A battery of 14 neuropsychological tests was administered to 844 individuals from a Finnish familial schizophrenia cohort. We grouped the applied neuropsychological tests into five factors for further analysis. Cognitive endophenotypes, whole blood mRNA, genotype, and medication use data were studied from 47 individuals. Expression level of several RNA probes were significantly associated with cognitive performance. The factor representing Verbal Working Memory was associated with altered expression levels of 11 probes, of which one probe was also associated with a specific sub-measure of this factor (WMS-R Digit span backward). While, the factor Processing speed was related to one probe, which additionally associated among 55 probes with a specific sub-measure of this factor (WAIS-R Digit symbol). Two probes were associated with the measure recognition memory performance. Enrichment analysis of these differentially expressed probes highlighted immunological processes. Our findings are in line with genome-wide genetic discoveries made in schizophrenia, suggesting that immunological processes may be of biological interest for future drug design towards schizophrenia and the cognitive dysfunctions that underlie it.

Variants in regulatory elements of PDE4D associate with major mental illness in the Finnish population

“…Most of the endophenotypes were normally distributed, however the Trail Making and Stroop tasks were transformed so that the scores represented speed (number of items/performance time). As the neuropsychological endophenotypes are related, they could be grouped into five first-order factors using factor analysis (Table2), and a second-order general ability factor (g-factor) based upon previous results (45) for cognition related traits. The factor analysis was performed with Mplus 7.3.…”

Potentially repurposable drugs for schizophrenia identified from its interactome

“…These genes may uncover novel pathways underlying some behavioral trait contributing to disease etiology. For example, it was recently shown that expression of genes associated with immunological processes vary with cognitive performance in familial schizophrenia 21 . So, our method to identify repurposable drugs may be tested on schizophrenia, in which differential gene expression plays a critical role.…”

Genetic and functional analysis reveals TENM4 contributes to schizophrenia

“…Many common genetic variants and rare functional mutations make up the polygenic architecture of SCZ (Henriksen et al, 2017). In SCZ, common and rare genetic variants are associated with disorders of -Vuoti et al, 2019;Boyajyan et al, 2015;Jiang et al, 2020). In this study, we focused on rare functional mutations with minor allele frequency (MAF) < 0.01 in the candidate gene, TENM4.…”